{"transactions":[{"id":791239,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-05T20:15:15.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":36375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of May 1, 2025, subject to the Continuous Service (as defined in the Issuer's 2024 Inducement Plan) of the Reporting Person as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of May 1, 2025, subject to the Continuous Service (as defined in the Issuer's 2024 Inducement Plan) of the Reporting Person as of each such date."}],"balance_after":109125,"derivative":{"underlying":"Common Stock","underlying_shares":36375},"source":{"system":"sec-edgar","filing":"0002065269-26-000004","document":"form4-05052026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000206526926000004/form4-05052026_040505.xml","form_type":"4"}},{"id":791238,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:15:15.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9330,"price":4.41,"value":41145.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4."}],"balance_after":27045,"source":{"system":"sec-edgar","filing":"0002065269-26-000004","document":"form4-05052026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000206526926000004/form4-05052026_040505.xml","form_type":"4"}},{"id":791237,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:15:15.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":36375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":36375,"source":{"system":"sec-edgar","filing":"0002065269-26-000004","document":"form4-05052026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000206526926000004/form4-05052026_040505.xml","form_type":"4"}},{"id":915780,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-06T23:04:49.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":343300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":343300,"derivative":{"exercise_price":3.61,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":343300},"source":{"system":"sec-edgar","filing":"0002065269-26-000002","document":"form4-02062026_110246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000206526926000002/form4-02062026_110246.xml","form_type":"4"}},{"id":915779,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-06T23:04:49.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":98100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":98100,"derivative":{"underlying":"Common Stock","underlying_shares":98100},"source":{"system":"sec-edgar","filing":"0002065269-26-000002","document":"form4-02062026_110246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000206526926000002/form4-02062026_110246.xml","form_type":"4"}},{"id":1158688,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-05-05T20:32:56.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":510000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of May 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":510000,"derivative":{"exercise_price":1.38,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":510000},"source":{"system":"sec-edgar","filing":"0001415889-25-011966","document":"form4-05052025_080553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000141588925011966/form4-05052025_080553.xml","form_type":"4"}},{"id":1158687,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":49612,"kind":"person","name":"Hall Jesse Wayne","position":1,"cik":"0002065269","reported_name":"Hall Jesse Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-05T20:32:56.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":145500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of May 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of May 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date."}],"balance_after":145500,"derivative":{"underlying":"Common Stock","underlying_shares":145500},"source":{"system":"sec-edgar","filing":"0001415889-25-011966","document":"form4-05052025_080553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000141588925011966/form4-05052025_080553.xml","form_type":"4"}}]}